TABLE 6.
Pilgaard et al. (17) | Wagan et al. (18) | Kozłowska et al. (33) | Present study | |
Study type | Cross-sectional | Cross-sectional | Cross-sectional | Case-control |
Country | Denmark | Pakistan | Poland | Spain |
Number of patients | 293 | 192 | 128 | 191 |
Age (years) | 57.4 ± 14 | 39.9 ± 10.5 | 53.8 ± 14.5 | 67.5 ± 8.8 |
Female | 79% | 71,9% | 85.9% | 100% |
Disease duration (years) | > 10 yrs: 60% | 6.85 ± 4.39 | 11.0 ± 9.0 | 16.8 ± 10.3 |
DAS28 | 2.48 ± 1.11 | < 3.2: 56.8% | 3.8 ± 0.9 | 2.9 ± 1.1 |
FACIT-F | 34.86 ± 11.04 | 34.94 ± 8.8 | 24.1 ± 9.1 | 36.0 ± 10.6 |
Prevalence of fatigue (FACIT-F < 40) |
59% | 62% | ND | 61% |
DAS28, Disease Activity Score 28; FACIT-T, Functional Assessment of Chronic Illness Therapy-Fatigue.